Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids

Keyphrases

• Organoids 100%
• Medium Throughput 100%
• Screening Assays 100%
• Radiotherapy 100%
• Patient-derived Organoids 100%
• Tumor 50%
• Growth Rate 50%
• Cell Survival 50%
• Organoid Culture 50%
• Drug Screening 50%
• Long-term Expansion 50%
• Clinical Application 50%
• Treatment Modalities 50%
• Tumor Morphology 50%
• Tumor Tissue 50%
• Long-term Maintenance 50%
• Near-native 50%
• Adenosine Triphosphate 50%
• Colorectal Adenocarcinoma 50%
• Therapy Response 50%
• Tumor Organoids 50%
• Area under the Curve 50%
• Organoid Models 50%
• Biobank 50%
• In Vivo Exposure 50%
• Single Treatment 50%
• Head-and-neck Squamous Cell Carcinoma (HNSCC) 50%
• Native State 50%
• Drug Sensitivity 50%
• Chemoradiotherapy 50%
• IC50 50%
• Primary Epithelial Cells 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Patient-Derived Organoid 100%
• IC50 66%
• Adenosine Triphosphate 33%
• Colorectal Carcinoma 33%
• Drug Screening 33%
• Chemotherapy 33%
• Head and Neck Squamous Cell Carcinoma 33%

Medicine and Dentistry

• Organoid 100%
• Radiation Therapy 100%
• Neoplasm 37%
• In Vitro 25%
• IC50 25%
• Adenosine Triphosphate 12%
• Colorectal Carcinoma 12%
• Epithelial Cell 12%
• Drug Screening 12%
• Treatment Response 12%
• Cell Survival 12%
• Head and Neck Squamous Cell Carcinoma 12%
• Drug Sensitivity 12%
• Drug Exposure 12%
• Tumor 12%
• Treatment Modality 12%